The Area assembles the know-how and technological platforms for the study of cellular mechanisms of disease, identification/validation of therapeutic targets and their exploitation in the design and synthesis of new candidate molecules for diagnostic and therapeutic development. The approach is based on the confluence of expertise in organic and pharmaceutical chemistry, cell physiology and pharmacology. Synergy between such components covers the best part of preclinical drug development.
Medicinal and organic chemistry
Barbara Simona Costa